D

Domain TherapeuticsPharmaceutical Manufacturing · 51-200 · B2B contacts & data

2 Decision makers
200 Employees
$18M Revenue
2008 Founded

Decision Makers at Domain Therapeutics

Total identified

2 decision makers identified 2 Heads
Preview available contacts
Decision maker Email Phone

Create a free Zeliq account to access their verified emails and direct phone numbers.

See 2 decision makers on Zeliq →

Team Structure headcount by department

Research
9
Other
5
General Management
3
Project Management
3
Technical
3
Education
2
Finance
2
Legal
2

Funding

Last round Other · $10M
Total funding $93M (11 rounds)
Corporate Round N/A Oct 2001
Series A $3M Feb 2002
Series B $16M May 2004
Series C $8M Oct 2006
Series D $2M Dec 2008
Venture Round $2M Jul 2012
Grant $230K Apr 2014
Venture Round $4M May 2019
Debt Financing $6M Jan 2020
Series A $42M May 2022
Grant $10M Jan 2024

Companies similar to Domain Therapeutics

About Domain Therapeutics

Domain Therapeutics operates in the Pharmaceutical Manufacturing industry, operating from France. Established in 2008, it employs approximately 200 people. Within the wider Manufacturing sector, Domain Therapeutics focuses on the Pharmaceutical Manufacturing segment. Domain Therapeutics is a B2B company, primarily serving business clients and professional organisations. The company has secured 11 rounds of funding totalling $93M. Its estimated yearly revenue stands at about $18M. Sales teams can rely on this profile to qualify Domain Therapeutics, spot business signals, and connect with verified decision makers.

Activity & Market

The company evolves in the Pharmaceutical Manufacturing segment of the Manufacturing sector. As a B2B company, Domain Therapeutics primarily serves business clients and professional organisations. In terms of structure, it is registered as “Privately held”.

How to prospect Domain Therapeutics's departments

Research

With 9 people, this is the organisation's biggest team. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Other

The company's second-largest department (5 people). Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

General Management

This department counts 3 people. General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.

Project Management

3 people work in this department. These profiles own delivery: anything that de-risks a milestone gets their attention.

Technical

A team of 3 people. Developer experience and integration effort will make or break your pitch here.

Education

This department counts 2 people. Training teams are judged on skill development: completion rates and learner engagement are the metrics to speak to.

FAQ Domain Therapeutics

What industry does Domain Therapeutics operate in?

Domain Therapeutics is active in the Pharmaceutical Manufacturing industry, specifically in the Manufacturing category.

How many employees does Domain Therapeutics have?

Domain Therapeutics has approximately 200 employees (in the 51-200 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Domain Therapeutics?

Zeliq lets you identify decision makers at Domain Therapeutics, enrich their professional contact details (verified emails and direct phone numbers), and launch targeted multichannel prospecting sequences.

Where is Domain Therapeutics headquartered?

Domain Therapeutics is headquartered in France.

What is the organizational chart of Domain Therapeutics?

Roles identified within Domain Therapeutics's organization include Head of Legal, Chairwoman of the Board. With Zeliq, you can enrich each of these roles with verified emails and direct phone numbers.

Why use this data before prospecting Domain Therapeutics?

Knowing Domain Therapeutics's industry, headcount, and business signals lets you personalise your outreach, prioritise high-potential accounts, and reach the right decision makers from the very first contact.